Biogen Inc. buy Royal Bank of Canada
Start price
01.08.25
/
50%
€114.05
Target price
01.08.26
€191.89
Performance (%)
2.06%
Price
25.09.25
€116.40
Summary
This prediction is currently active. With a performance of 2.06%, the BUY prediction by Royal_Bank_of_Canada for Biogen Inc. is trending in the right direction. This prediction currently runs until 01.08.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -4.590% | -4.590% |
| iShares Core DAX® | -0.581% | -2.940% |
| iShares Nasdaq 100 | 0.824% | 3.718% |
| iShares Nikkei 225® | -0.630% | 5.126% |
| iShares S&P 500 | 0.643% | 2.253% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank Of Canada from $208.00 to $219.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat